This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
The Washington Post
washingtonpost.com
did:plc:k5nskatzhyxersjilvtnz4lh
Retatrutide is not Ozempic, which activates GLP-1 receptors. And it’s not or Mounjaro or Zepbound, which activate both the GLP-1 and GIP receptors. Reta is called a “triple agonist.” That means it activates GLP-1, GIP and glucagon receptors.
Here’s why it’s popular:
https://www.washingtonpost.com/style/2026/07/02/retatrutide-is-exploding-online-is-it-legal-sorta/?utm_campaign=wp_main&utm_source=bluesky&utm_medium=social
2026-07-03T17:00:17.220Z